NAT2 and urinary bladder cancer: This means that in ultra-slow NAT2 acetylators, the oxidative metabolic pathway is followed to a relevant extent, which ultimately leads to arylnitrenium ions, which, according to current knowledge, are the metabolites of carcinogenic aromatic amines that trigger bladder cancer (Hein et al., 1992[26]).